1Gilbert RE, Krum H, Wilkinson-Berka J, et al. The reninangiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations[J].Diabet Med, 2003 ,20(8) :607 - 621.
2Hall J. Historical perspective of the renin-angiotensin system [J]. Mol Biotechnol , 2003, 24(1):27-39.
3Re RN. Tissue renin angiotensin systems[J]. Med Clin North Am, 2004,88(1): 19 - 38.
4Leung PS, Carlsson PO. Tissue renin-angiotensin system:its expression, localization, regulation and potential role in the pancreas[J]. J Mol Endocrinol, 2001, 26(3): 155 -164.
5Nap A, Belterman CN, Mathy MJ, et al. Impaired neuronal and vascular responses to angiotensin Ⅱ in a rabbit congestive heart failure model[J]. J Renin Angiotensin Aldosterone Syst, 2003,4(4) :220 - 227
6Stanton A. Potential of renin inhibition in cardiovascular disease[ J]. J Renin Angiotensin Aldosterone Syst, 2003, 4(1):6- 10.
7Grant R W, Cagliero E, Murphy-Sheehy P, et al. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes[ J].Am J Med, 2002, 112(8):603-609.
8Carr ME. Diabetes mellitus: a hypercoagulable state[J].J Diabetes Complications, 2001,15(1):44-54.
9Taylor AA. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus [ J ]. Endocrinol Metab Clin North Am, 2001, 30(4) :983 - 997.
10Anderson RA, Evans ML, Ellis GR, et al. The relationships between post-prandial lipidemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes[J]. Atherosclerosis, 2001, 154(2): 475 -483.
10Carey RM.Sirngy HM.Newly recognized com ponents of the renin-angiotensin system:potential roles in cardiovascular and renal regulation[J].Endocrine Reviews,2003;24:261-271
